Sir Andrew Witty

Sir Andrew Witty
Name	Andrew Witty
Honorific prefix	Sir
Birth date	1964
Birth place	Keighley, West Yorkshire, England
Occupation	Businessman, executive, healthcare leader
Alma mater	University of Nottingham
Known for	Chief Executive Officer of GlaxoSmithKline, CEO of Optum Europe / UnitedHealth Group

Sir Andrew Witty Sir Andrew Witty is a British business executive and healthcare leader known for leading multinational pharmaceutical and health services companies. He served as Chief Executive Officer of GlaxoSmithKline and later held senior roles at UnitedHealth Group and in UK public service initiatives. Witty has been prominent in debates on access to medicines, pharmaceutical innovation, and public–private partnerships involving institutions such as the World Health Organization, Gavi, the Vaccine Alliance, and the Bill & Melinda Gates Foundation.

Early life and education

Witty was born in Keighley, West Yorkshire and grew up in a working-class family in England. He studied economics and modern history at the University of Nottingham, later completing a management development programme associated with INSEAD and executive education at Harvard Business School. His formative years included early employment with Glaxo before the GlaxoWellcome and SmithKline Beecham merger that created GlaxoSmithKline.

Career at GlaxoSmithKline

Witty joined Glaxo as a graduate trainee and moved through roles in sales and marketing across Europe, including postings in Chile, Colombia, and South Africa. He rose to global leadership positions, including President of GSK Pharmaceuticals and CEO of GlaxoSmithKline from 2008 to 2017. During his tenure he navigated product portfolios containing medicines and vaccines for conditions addressed by HIV/AIDS programmes, malaria initiatives supported by Roll Back Malaria, and vaccine collaborations involving Sanofi and Pfizer. Witty oversaw transactions and restructuring that intersected with multinational corporations such as Novartis, AstraZeneca, Roche, Johnson & Johnson, and Merck & Co..

Leadership and business strategy

As CEO, Witty articulated strategies combining research and development partnerships with mergers, divestments, and commercial optimisation. He promoted open innovation and alliances with academic centres such as Imperial College London, University of Oxford, and University of Cambridge and fostered collaborations with biomedical institutes including the NIHR and Wellcome Trust. Witty championed pricing models and access programmes engaging stakeholders like Médecins Sans Frontières, Clinton Health Access Initiative, and the Global Fund to Fight AIDS, Tuberculosis and Malaria. Strategic moves included negotiations with corporate partners and investors including BlackRock, The Carlyle Group, and sovereign investors from Qatar and Singapore.

Public service and healthcare policy

Beyond corporate roles, Witty advised governments and international organisations. He served on advisory boards linked to the UK Department of Health, engaged with the World Economic Forum in Davos, and worked alongside global health actors such as the Global Alliance for Vaccines and Immunization and the United Nations agencies. Witty accepted an interim position as Chief Executive of the NHS during discussions about integrating private sector capabilities with public health delivery, interacting with policymakers from Westminster and health leaders from Scotland and Wales. His public service involvement included participation in pandemic preparedness dialogues with the Centers for Disease Control and Prevention, European Medicines Agency, and the Coalition for Epidemic Preparedness Innovations.

Awards, honours and honours controversies

Witty was knighted, receiving a knighthood and was recognised by business schools and professional bodies including The Financial Times rankings and honours from the Institute of Directors. He accepted appointments to boards and advisory councils such as those of AstraZeneca competitors and philanthropic organisations including the Bill & Melinda Gates Foundation; these roles provoked scrutiny concerning conflicts of interest debated in media outlets like The Guardian, The Telegraph, and The New York Times. Parliamentary questions in the House of Commons and commentary from think tanks including the Royal Society and Chatham House addressed ethical considerations about corporate executives holding public advisory positions. Academic critics from institutions like London School of Economics and organisations including Transparency International raised concerns prompting disclosures and governance reviews.

Personal life and philanthropy

Witty is married and has family ties in Yorkshire; he has lived in locations associated with his global career including London and international postings. He has supported philanthropic efforts through foundations and collaborations with charities such as Oxfam, Save the Children, UNICEF, and health research funders including Cancer Research UK and the Wellcome Trust. His charitable interests have encompassed global health equity, vaccine access, and medical research funding, often working with donor consortia including Gates Foundation partners and multilateral initiatives like Gavi and the Global Fund.

Category:British chief executives Category:Alumni of the University of Nottingham Category:Knights Bachelor